Quick Takeaways
- Parag Mallick filed SCHEDULE 13D/A for Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT).
- Disclosed ownership: 18%.
- Date of event: 02 Mar 2026.
Parag Mallick - 02 Mar 2026 SCHEDULE 13D/A Report for Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT)
- Filing Manager
- Parag Mallick
- Reporting Manager
- Parag Mallick
- Symbol
- NAUT
- Shares outstanding
- 128,167,108 shares
- Disclosed Ownership
- 22,557,411 shares
- Ownership
- 18%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Mar 2026, 19:33:03 UTC
- Date of event
- 02 Mar 2026
- Previous filing
- 05 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Parag Mallick disclosed 18% ownership in Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT) on 02 Mar 2026."
What Changed
- Previous schedule filing date: 05 Mar 2025.
- Current filing was accepted on 04 Mar 2026, 19:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Parag Mallick | 18% | 22,557,411 | 22,357,411 | 200,000 | /s/ Matthew Murphy | Matthew Murphy/Attorney-in-fact | 0001857948 |